![]() |
|
|
Forward to a colleague |
||
Product Overview ![]() Pharmatest offers unique preclinical in vitro and in vivo drug efficacy testing services to pharmaceutical companies developing new drugs against osteoporosis, cancer or osteoarthritis. Our services can also be used for testing existing compounds for possible adverse effects on bone or secondary indication for bone-related diseases, as well as development of functional foods for bone health... Click Here Access Full Stories A team of scientists at Biogen Idec have unveiled preclinical data for a potential protein therapeutic to treat Alzheimer's, a disease normally only attacked using small molecules due to delivery issues... Read Merck-Frosst pushing mass spectroscopy into overdrive Merck-Frosst Canada is pushing the limits of mass spectroscopy (MS), hoping to speed it up enough to achieve true high-throughput screening of difficult drug targets... Read Award for preclinical services firm Domainex, a London- and Cambridge-based preclinical services firm has won an industry award for its bottleneck-breaking genomics technology... Read Bayer pipeline in good shape as merger rumours build Analysts believe Bayer's research and development pipeline is well equipped to deal with looming patent expiries but that didn't stop rumours of a Novartis buyout last week... Read Amgen's approach to selectivity predictions Amgen has outlined how it uses computer models to predict the selectivity of small molecule drugs... Read |
||||||||||||||
All News Headlines for: August | July | June |
||||||||||||||
|
deltaDOT label free analysis of biomolecules Faster, higher quality results at a fraction of the cost of conventional approaches. Analyse & Quantify Antibodies, Proteins and Small molecules - with high resolution, sensitivity & reproducibility... Click Here |
||||||||||||||
|
Related Industry News North American CROs continue emerging market moves Two North American contract research organisation (CROs) have this week announced acquisitive moves into emerging clinical trials markets, while a third firm has extended an Asian partnership, as the emerging market... Read GSK, MSD move on Singapore schemes GlaxoSmithKline (GSK) and Merck Sharp & Dohme (MSD) have made further moves in their plans to boost their presence in Singapore, a region growing in popularity for biopharmaceutical research and manufacture... Read Vivalis scores another cell culture technology French biopharmaceutical company Vivalis has added another cell culture technology to its stronghold as it moves to dominate the avian stem cell market... Read United Drug makes second EU packaging purchase United Drug has made its second European contract packaging purchase as the Irish services firm continues to pursue expansion across the continent... Read
|
||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||